Cooling therapy for mild traumatic brain injury in adolescents
Official title: A Double-Blind, Randomized Study of Clinical Efficacy of Hypothermic Therapy Following Concussion in Adolescent Athletes as Compared to a Sham-Controlled Population
Run by TecTraum Inc. · NCT06929923 · Data updated 2026-11-12
This study is testing if a cooling device can help young athletes aged 12-21 recover better from mild brain injuries they got while playing sports.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 21 Years |
| Sex | All |
| Enrollment | 66 (estimated) |
| Sponsor | TecTraum Inc. Industry-sponsored |
| Locations | 3 sites (Ann Arbor, Michigan and 2 other locations) |
| Status | Recruiting |
| Started | February 20, 2025 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT06929923 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 12-21 who have recently been diagnosed with a mild traumatic brain injury from sports activities.
✕Probably not a fit
Patients who have been cleared to return to play or who have sustained a more serious traumatic brain injury will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and effectiveness of the Pro-2-Cool device, which provides non-invasive cooling to the head and neck, in adolescents aged 12-21 who have sustained a mild traumatic brain injury (mTBI) during sports activities. It is a multi-center, prospective, randomized, non-blinded, dual-arm comparator study enrolling up to 72 patients, with half receiving the cooling treatment and the other half serving as a control group. The goal is to determine if this cooling therapy can improve recovery outcomes for young athletes after mTBI.
Why it matters
Potential benefit: If successful, this approach could lead to improved recovery times and outcomes for adolescents suffering from mild traumatic brain injuries.
How similar studies have gone: While the use of cooling therapies in brain injury is an emerging field, this specific approach using the Pro-2-Cool device has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Males and females, 13-21 years of age 2. Confirmed concussion diagnosis consistent with American Congress Rehabilitation Medicine guidelines 21, without any of the following: * Glasgow Coma Scale (GCS) score of less than 13 at 30 minutes post-injury * Loss of consciousness greater than 30 minutes * Post-traumatic amnesia lasting over 24 hours 3. Glasgow Coma Scale (GCS) ≥ 13 at the time of initial injury for study enrollment. 4. Post-Concussion Symptom Scale Score minimum of 15 5. Initial provider visit is within 7 days of injury 6. In generally good health as confirmed by medical history and determined by site investigator or designated trained healthcare professional under the supervision of the principal investigator. 7. Has informed consent obtained per protocol and as required per Institutional Review Board Exclusion Criteria: 1. Age \< 13 years or \> 21 years 2. Inability to understand the study requirements or provide informed consent 3. Cleared to return to play during initial visit 4. Prior participation in a Pro2Cool Clinical Study 5. Serious traumatic brain injury as evidenced by worsening symptoms: * Vomiting \> 2 episodes following injury * Seizure * Hospitalization * Radiology scan indicating brain bleed * Slurred speech which has not resolved within 72 hours of concussive injury 6. Physical (e.g., head or neck injury that requires medical treatment) or mental disability hindering adequate response to assessment of symptoms 7. Hemodynamic instability/medical condition requiring further acute life-saving medical intervention 8. History of psychiatric disorder that includes suicide attempts within the last 6 months, unmanaged depression or anxiety, hospitalization for psychiatric treatment within the last 6 months 9. Known brain mass, intracranial hemorrhage, skull fracture 10. Scalp abnormalities including laceration or bleeding 11. Presence of ventriculoperitoneal (VP) shunt 12. Known hematological malignancies, including, but not limited to: multiple myeloma, leukemia, and lymphoma 13. Known history of Reynaud's Disease compromised liver function, cold agglutination, cold sensitivity, cryoglobulinemia, cryofibrinogenemia, and/or a history of severe migraines 14. Known or disclosed pregnancy or breast-feeding 15. Sustains another head or neck injury at the time of concussive injury which requires medical treatment
Where it's running
-
Akron Children's Hospital
Akron, Ohio, United States Recruiting -
University of Michigan
Ann Arbor, Michigan, United States Not yet recruiting -
Cleveland Clinic Foundation
Cleveland, Ohio, United States Not yet recruiting
Study contacts
- Principal investigator: Brian Reilly, MD — Children's Hospital Medical Center of Akron
- Study coordinator: John Zak, MD, MBA
- Email: jzak@tectraum.com
- Phone: 216-789-7676
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tinted daily contact lenses for light sensitivity after a concussion
This project will try daily disposable tinted contact lenses to reduce light sensitivity in adults who have had a mild concussion.
-
Combining Acceptance and Commitment Therapy with Vestibular Rehabilitation for mTBI
This study is testing if combining a therapy that helps with acceptance and commitment with standard balance exercises can better help military service members with mild traumatic brain injury and related symptoms feel better.
-
Automated virtual reality therapy for eye recovery after brain injury
This study tests a new virtual reality therapy to see if it can help veterans with vision problems after a brain injury feel better.
-
Improving access to specialty care for concussion patients
This study is testing a new mobile health program to help concussion patients get better care faster and improve their recovery by allowing them to share their symptoms daily with doctors.
-
Rapid, accurate, low-cost blood test to help diagnose concussion
This study will test if a portable biosensor can accurately measure a blood biomarker (GFAP) to help diagnose concussion in adults who come to the emergency department.
-
Traq device test of binocular eye function in people with and without a concussion
This study tests the Traq device to see how well binocular eye function works in healthy people compared with people who recently had a mild-to-moderate traumatic brain injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.